{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-334588","form_type":"8-K","ticker":"NGNE","cik":"0001404644","company_name":"Neurogene Inc.","filed_at":"2021-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.400114+00:00","generated_at":"2026-06-28T06:28:45.840137+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Neoleukin Therapeutics General Counsel Holly Vance resigns","bullets":["Holly Vance resigns as General Counsel and Corporate Secretary effective Nov 17, 2021 to pursue another opportunity.","Transition period under negotiation; Vance expected to provide consulting services as needed.","No replacement named; CFO Robert Ho signs the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-334588","json":"https://secwatch.observer/filing/0001193125-21-334588.json","markdown":"https://secwatch.observer/filing/0001193125-21-334588.md","text":"https://secwatch.observer/filing/0001193125-21-334588.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1404644/000119312521334588/0001193125-21-334588-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1404644/000119312521334588/d259869d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T06:28:45.840137+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"17efa45130","claim":"Holly Vance resigned as General Counsel and Corporate Secretary at Neurogene Inc..","evidence_excerpt":"On November 17, 2021, Neoleukin Therapeutics, Inc. (the “Company”) received notice from Holly Vance of her intention to resign as the Company’s General Counsel and Corporate Secretary to pursue another opportunity.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1404644/000119312521334588/0001193125-21-334588-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"General Counsel and Corporate Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}